Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01692340 · ClinicalTrials.gov registry record · Phase 1
Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans
A Phase 1 study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01692340 is a Phase 1 study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 12 participants.
The verdict
NCT01692340, a Phase 1 study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Tomatoes contain several compounds which may be beneficial for human health and prevention of disease, although this relationship is poorly understood and very controversial. This study uses a new technology to study the absorption and metabolism of three different compounds found in tomatoes. These compounds are called: phytoene, phytofluene, and lycopene. We hypothesize that by studying the absorption and metabolism of these compounds, we may be able to understand how the compounds may influence health and disease processes.
Interventions
- OTHER Isotopically labeled lycopene, phytoene or phytofluene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01692340
The ClinicalTrials.gov registry entry for NCT01692340 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Isotopically labeled lycopene, phytoene or phytofluene is the first listed.
NCT01692340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01692340 about?
NCT01692340 is a clinical study titled "Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans". Tomatoes contain several compounds which may be beneficial for human health and prevention of disease, although this relationship is poorly understood and very controversial. This study uses a new technology to study the absorption and metabolism of three different compounds found in tomatoes. These...
What is the current status of trial NCT01692340?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2012-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01692340?
The interventions under investigation include: Isotopically labeled lycopene, phytoene or phytofluene (OTHER).
Who is sponsoring clinical trial NCT01692340?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.